(IBHJ) iShares Trust - iShares - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E1221

High-Yield, Bonds, Fixed Income, Securities

Description: IBHJ iShares Trust - iShares

The iShares iBonds 2030 Term High Yield and Income ETF is a targeted maturity ETF that focuses on investing in high-yield bonds with maturities around 2030, providing a predictable income stream and potentially lower interest rate risk as the bonds mature.

To achieve its objective, the fund will allocate a minimum of 80% of its assets to the constituent securities of its underlying index, ensuring a high degree of tracking accuracy. Furthermore, at least 90% of its assets will be invested in fixed-income securities that mirror the composition of the underlying index, as determined by BlackRock Fund Advisors (BFA). This strategy is designed to replicate the performance of the underlying index, which is likely composed of high-yield bonds with a maturity profile centered around 2030.

As a non-diversified fund, the ETF may have a higher concentration of risk compared to diversified funds, potentially leading to greater volatility. However, this concentrated approach can also result in higher returns if the selected bonds perform well.

Analyzing the available technical data, the ETFs recent price action indicates a slight uptrend, with the last price of $26.21 being close to its 52-week high of $26.23. The short-term and long-term moving averages (SMA20, SMA50, and SMA200) are all below the current price, suggesting a positive momentum. The Average True Range (ATR) of 0.29, or 1.11%, indicates relatively moderate volatility.

Considering the fundamental data, the funds Assets Under Management (AUM) stand at $55.50 million, which is a relatively modest size. This could potentially impact liquidity, but it also indicates that the fund is still in its growth phase.

Forecasting the ETFs future performance, we can expect the fund to continue its current uptrend if the underlying high-yield bonds maintain their performance and the overall market conditions remain favorable. The approaching maturity of the bonds in 2030 will likely reduce interest rate risk, potentially leading to more stable returns. However, the high-yield nature of the bonds means that credit risk remains a significant factor. If the current trend continues, we can expect the ETFs price to potentially reach $27.00-$28.00 in the next 6-12 months, based on the current momentum and assuming stable market conditions.

IBHJ ETF Overview

Market Cap in USD 71m
Category Target Maturity
TER 0.35%
IPO / Inception 2023-06-21

IBHJ ETF Ratings

Growth Rating 77.6%
Fundamental -
Dividend Rating 58.1%
Return 12m vs S&P 500 -9.91%
Analyst Rating -

IBHJ Dividends

Dividend Yield 12m 6.26%
Yield on Cost 5y 7.61%
Annual Growth 5y 37.16%
Payout Consistency 100.0%
Payout Ratio %

IBHJ Growth Ratios

Growth Correlation 3m 94.3%
Growth Correlation 12m 83.4%
Growth Correlation 5y 97.4%
CAGR 5y 10.51%
CAGR/Max DD 3y 2.13
CAGR/Mean DD 3y 29.11
Sharpe Ratio 12m 0.37
Alpha -10.67
Beta 0.820
Volatility 4.21%
Current Volume 10.6k
Average Volume 20d 13.8k
Stop Loss 25.8 (-3.3%)
Signal -0.05

What is the price of IBHJ shares?

As of September 13, 2025, the stock is trading at USD 26.68 with a total of 10,570 shares traded.
Over the past week, the price has changed by +0.10%, over one month by +1.31%, over three months by +3.24% and over the past year by +7.26%.

Is iShares Trust - iShares a good stock to buy?

Yes. Based on ValueRay's Analyses, iShares Trust - iShares (BATS:IBHJ) is currently (September 2025) a good stock to buy. It has a ValueRay Growth Rating of 77.63 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBHJ is around 26.96 USD . This means that IBHJ is currently overvalued and has a potential downside of 1.05%.

Is IBHJ a buy, sell or hold?

iShares Trust - iShares has no consensus analysts rating.

What are the forecasts/targets for the IBHJ price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 30.2 13.2%

Last update: 2025-09-05 04:46

IBHJ Fundamental Data Overview

Market Cap USD = 71.4m (71.4m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 71.4m USD (71.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 71.4m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 71.4m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(71.4m)/V(0.0) * Re(9.04%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.04% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBHJ ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle